Aethlon Medical (AEMD) Competitors

Aethlon Medical logo
$5.46 +0.62 (+12.81%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$5.42 -0.04 (-0.64%)
As of 11/20/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AEMD vs. PAVM, PETV, GUTS, IRIX, and FEMY

Should you buy Aethlon Medical stock or one of its competitors? Aethlon Medical's main competitors and comparable companies include PAVmed (PAVM), PetVivo (PETV), Fractyl Health (GUTS), IRIDEX (IRIX), and Femasys (FEMY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Aethlon Medical compare to PAVmed?

PAVmed (NASDAQ:PAVM) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, PAVmed had 1 more articles in the media than Aethlon Medical. MarketBeat recorded 1 mentions for PAVmed and 0 mentions for Aethlon Medical. PAVmed's average media sentiment score of 0.52 beat Aethlon Medical's score of 0.00 indicating that PAVmed is being referred to more favorably in the media.

Company Overall Sentiment
PAVmed Positive
Aethlon Medical Neutral

PAVmed has higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PAVmed$70K129.71$400K-$9.11N/A
Aethlon MedicalN/AN/A-$7.15M-$18.87N/A

PAVmed has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

19.9% of PAVmed shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 13.4% of PAVmed shares are held by insiders. Comparatively, 0.6% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Aethlon Medical has a net margin of 0.00% compared to PAVmed's net margin of -12,406.76%. PAVmed's return on equity of -61.95% beat Aethlon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
PAVmed-12,406.76% -61.95% -17.08%
Aethlon Medical N/A -141.23%-115.44%

PAVmed presently has a consensus price target of $56.00, suggesting a potential upside of 4,833.92%. Aethlon Medical has a consensus price target of $1.50, suggesting a potential downside of 72.53%. Given PAVmed's stronger consensus rating and higher possible upside, analysts clearly believe PAVmed is more favorable than Aethlon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PAVmed
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Aethlon Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Summary

PAVmed beats Aethlon Medical on 12 of the 14 factors compared between the two stocks.

How does Aethlon Medical compare to PetVivo?

PetVivo (NASDAQ:PETV) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

24.5% of PetVivo shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 0.6% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aethlon Medical has a consensus target price of $1.50, suggesting a potential downside of 72.53%. Given Aethlon Medical's stronger consensus rating and higher probable upside, analysts clearly believe Aethlon Medical is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aethlon Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Aethlon Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Aethlon Medical's return on equity of -141.23% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
Aethlon Medical N/A -141.23%-115.44%

In the previous week, PetVivo's average media sentiment score of 0.00 equaled Aethlon Medical'saverage media sentiment score.

Company Overall Sentiment
PetVivo Neutral
Aethlon Medical Neutral

Aethlon Medical has lower revenue, but higher earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M11.05-$10.95M-$0.28N/A
Aethlon MedicalN/AN/A-$7.15M-$18.87N/A

PetVivo has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market.

Summary

Aethlon Medical beats PetVivo on 6 of the 11 factors compared between the two stocks.

How does Aethlon Medical compare to Fractyl Health?

Aethlon Medical (NASDAQ:AEMD) and Fractyl Health (NASDAQ:GUTS) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation and dividends.

Aethlon Medical has higher earnings, but lower revenue than Fractyl Health. Aethlon Medical is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aethlon MedicalN/AN/A-$7.15M-$18.87N/A
Fractyl Health$90K120.90-$140.95M-$3.11N/A

2.0% of Aethlon Medical shares are owned by institutional investors. 0.6% of Aethlon Medical shares are owned by company insiders. Comparatively, 8.4% of Fractyl Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Aethlon Medical has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.9, indicating that its share price is 190% more volatile than the broader market.

Aethlon Medical's return on equity of -141.23% beat Fractyl Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Aethlon MedicalN/A -141.23% -115.44%
Fractyl Health N/A -2,114.58%-91.50%

In the previous week, Fractyl Health had 7 more articles in the media than Aethlon Medical. MarketBeat recorded 7 mentions for Fractyl Health and 0 mentions for Aethlon Medical. Aethlon Medical's average media sentiment score of 0.00 beat Fractyl Health's score of -0.25 indicating that Aethlon Medical is being referred to more favorably in the media.

Company Overall Sentiment
Aethlon Medical Neutral
Fractyl Health Neutral

Aethlon Medical currently has a consensus target price of $1.50, indicating a potential downside of 72.53%. Fractyl Health has a consensus target price of $50.25, indicating a potential upside of 6,028.05%. Given Fractyl Health's stronger consensus rating and higher possible upside, analysts clearly believe Fractyl Health is more favorable than Aethlon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aethlon Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Fractyl Health
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Fractyl Health beats Aethlon Medical on 9 of the 13 factors compared between the two stocks.

How does Aethlon Medical compare to IRIDEX?

Aethlon Medical (NASDAQ:AEMD) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 0.6% of Aethlon Medical shares are held by insiders. Comparatively, 8.6% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Aethlon Medical presently has a consensus target price of $1.50, indicating a potential downside of 72.53%. IRIDEX has a consensus target price of $3.00, indicating a potential upside of 574.16%. Given IRIDEX's stronger consensus rating and higher possible upside, analysts clearly believe IRIDEX is more favorable than Aethlon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aethlon Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
IRIDEX
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

IRIDEX has higher revenue and earnings than Aethlon Medical. IRIDEX is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aethlon MedicalN/AN/A-$7.15M-$18.87N/A
IRIDEX$52.67M0.15-$4.44M-$0.19N/A

Aethlon Medical has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

Aethlon Medical has a net margin of 0.00% compared to IRIDEX's net margin of -6.88%. IRIDEX's return on equity of 0.00% beat Aethlon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Aethlon MedicalN/A -141.23% -115.44%
IRIDEX -6.88%N/A -12.55%

In the previous week, IRIDEX had 10 more articles in the media than Aethlon Medical. MarketBeat recorded 10 mentions for IRIDEX and 0 mentions for Aethlon Medical. IRIDEX's average media sentiment score of 0.08 beat Aethlon Medical's score of 0.00 indicating that IRIDEX is being referred to more favorably in the news media.

Company Overall Sentiment
Aethlon Medical Neutral
IRIDEX Neutral

Summary

IRIDEX beats Aethlon Medical on 12 of the 14 factors compared between the two stocks.

How does Aethlon Medical compare to Femasys?

Femasys (NASDAQ:FEMY) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

In the previous week, Femasys had 1 more articles in the media than Aethlon Medical. MarketBeat recorded 1 mentions for Femasys and 0 mentions for Aethlon Medical. Femasys' average media sentiment score of 1.25 beat Aethlon Medical's score of 0.00 indicating that Femasys is being referred to more favorably in the media.

Company Overall Sentiment
Femasys Positive
Aethlon Medical Neutral

Femasys presently has a consensus price target of $10.00, indicating a potential upside of 706.45%. Aethlon Medical has a consensus price target of $1.50, indicating a potential downside of 72.53%. Given Femasys' stronger consensus rating and higher possible upside, research analysts plainly believe Femasys is more favorable than Aethlon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Femasys
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Aethlon Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Aethlon Medical has lower revenue, but higher earnings than Femasys. Femasys is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Femasys$2.29M4.69-$18.63M-$2.06N/A
Aethlon MedicalN/AN/A-$7.15M-$18.87N/A

Femasys has a beta of -2.13, meaning that its share price is 313% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

65.3% of Femasys shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 7.8% of Femasys shares are owned by company insiders. Comparatively, 0.6% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Aethlon Medical has a net margin of 0.00% compared to Femasys' net margin of -640.76%. Femasys' return on equity of -114.48% beat Aethlon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Femasys-640.76% -114.48% -59.84%
Aethlon Medical N/A -141.23%-115.44%

Summary

Femasys beats Aethlon Medical on 11 of the 14 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AEMD vs. The Competition

MetricAethlon MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3.56M$5.99B$7.75B$11.70B
Dividend YieldN/A1.69%2.48%4.66%
P/E Ratio-0.2938.2132.5328.82
Price / SalesN/A5.437.905.32
Price / CashN/A23.7921.0521.90
Price / Book0.644.014.263.50
Net Income-$7.15M$143.06M$3.51B$394.12M
1 Month Performance7.69%-8.30%-10.58%-12.04%
1 Year Performance-69.92%-4.45%-4.79%-11.42%

Aethlon Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AEMD
Aethlon Medical
0.4927 of 5 stars
$5.46
+12.8%
$1.50
-72.5%
-69.4%$3.56MN/AN/A9
PAVM
PAVmed
1.4771 of 5 stars
$1.51
-13.7%
$56.00
+3,608.6%
-89.4%$13.99M$70KN/A41
PETV
PetVivo
N/A$0.35
-32.0%
N/A-72.7%$13.49M$1.05MN/A22
GUTS
Fractyl Health
1.7041 of 5 stars
$0.97
-2.7%
$50.25
+5,105.1%
-94.7%$13.16M$90KN/A73
IRIX
IRIDEX
2.1814 of 5 stars
$0.70
+1.7%
$3.00
+328.8%
-52.7%$12.08M$52.67MN/A108

Related Companies and Tools


This page (NASDAQ:AEMD) was last updated on 11/21/2026 by MarketBeat.com Staff.
From Our Partners